ArticleDrug safety2025

Pregnancy and Infant Outcomes in Women with Multiple Sclerosis Exposed to Glatiramer Acetate Therapy: An Extended 4-Year Safety Update.

Sigal Kaplan et al.PubMed ↗Publisher ↗

No numbers read from the abstract.